Soudeh F. Tehrani

Jan 10, 2025 | outsourcedpharma.com | Peter H. Calcott |Louis Garguilo |Soudeh F. Tehrani |Lisa Lemelin

We’re ready to help usher your next drug into market! 2025’s first Outsourced Pharma Capacity Update provides a unique, virtual experience and the details necessary to find a CDMO for your specific timeline, volume, and production needs. Join us the last week of January as we draw the curtains on the industry’s best and give you complimentary VIP access to the resources available to support your success.

Jul 3, 2024 | outsourcedpharma.com | Louis Garguilo |Mark Witcher |Soudeh F. Tehrani |Lisa Lemelin

The U.S. House Rules Committee did not include the BIOSECURE Act in the final list of amendments for the National Defense Authorization Act (NDAA). Chief Editor Louis Garguilo has been outspoken in defending WuXi Apptec’s right to due process. Readers have responded in spades. Here's the latest.